Longeveron (LGVN) Cost of Revenue (2020 - 2026)

Longeveron (LGVN) recorded quarterly Cost of Revenue of $134000.0 in Q1 2026, up 24.07% quarter-over-quarter from $108000.0 in Q4 2025, and up 26.42% on a YoY basis from $106000.0 in Q1 2025.

Longeveron (LGVN) Cost of Revenue (2020 - 2026) Analysis & Trends

Longeveron's Cost of Revenue history runs 7 years deep, the most recent figure standing at $134000.0 for Q1 2026.

  • In Q1 2026, Cost of Revenue rose 26.42% year-over-year to $134000.0; the TTM figure through Mar 2026 stood at $424000.0 (up 7.61% YoY), while the FY2025 annual figure was $396000.0, down 22.05% from the prior year.
  • Cost of Revenue was $134000.0 for Q1 2026 at Longeveron, up from $108000.0 in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $502000.0 in Q4 2022 to a low of $12000.0 in Q3 2025.
  • Historically, Cost of Revenue has averaged $155235.3 across 5 years, with a median of $124000.0 in 2023.
  • The sharpest annual moves came in 2022 and 2023: Cost of Revenue soared 341.51% in 2022, then tumbled 87.05% in 2023.
  • A 5-year view of Cost of Revenue shows it stood at $502000.0 in 2022, then sank by 87.05% to $65000.0 in 2023, then rose by 12.31% to $73000.0 in 2024, then soared by 47.95% to $108000.0 in 2025, then increased by 24.07% to $134000.0 in 2026.
  • The last three Cost of Revenue figures came in at $134000.0 (Q1 2026), $108000.0 (Q4 2025), and $12000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 64.20 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 48,670.00
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 392.80 Mn
9 Abivax 91.96 Bn 91.96 Bn - 2.05 Mn
10 Longeveron 20.35 Bn 20.33 Bn 264,000.00 134,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 134,000.00
Mar 31, 2026 134,000.00
Dec 31, 2025 108,000.00
Dec 31, 2025 108,000.00
Sep 30, 2025 12,000.00
Sep 30, 2025 12,000.00
Jun 30, 2025 170,000.00
Jun 30, 2025 170,000.00
Mar 31, 2025 106,000.00
Mar 31, 2025 106,000.00
Dec 31, 2024 73,000.00
Dec 31, 2024 73,000.00
Sep 30, 2024 91,000.00
Sep 30, 2024 91,000.00
Jun 30, 2024 124,000.00
Jun 30, 2024 124,000.00
Mar 31, 2024 219,000.00
Mar 31, 2024 219,000.00
Dec 31, 2023 65,000.00
Dec 31, 2023 65,000.00